Both classic and more modern developmental biological experiments have shown that differentiation includes both the adoption of key cell fate markers as well as the restriction of developmental potential. The restriction of plasticity can be assayed by transcription factor (TF) overexpression experiments: the overexpression of a TF at an early stage of development often can induce the expression of its target genes, whereas overexpression in later stages has minimal to no effect, indicating a reduction in plasticity over developmental time. In order to understand this phenomenon, we generated mutants that lack the ability to restrict fate. In genetic screens we have isolated
usp-48, a conserved, ubiquitous nuclear deubiquitinase, as a key regulator of cell fate in the hypodermis. In such mutants, the hypodermis adopts its cell fate normally, but no longer inhibits the ability of an overexpressed TF to induce target gene expression. This function is cell-autonomous and depends on the deubiquitinating activity of USP-48. Studies with a temperature-sensitive mutant reveal that loss of USP-48 at any stage results in the ability of an overexpressed TF to induce its target genes, indicating a continuous requirement for its function. Interestingly, in addition to TF overexpression now being able to induce target genes, the hypodermis loses several cell fate characteristics in
usp-48 mutants upon TF overexpression. Using an improved INTACT protocol, we are generating and analyzing RNAseq profiles of wt and
usp-48 hypodermal cells in both normal and TF overexpression conditions in order to reveal the extent and specificity of the changes in the
usp-48 mutants upon TF overexpression. We have also begun to explore the mechanism of action of USP-48, which is likely affecting the nature of the chromatin landscape in the hypodermis during development. We have also isolated several new mutants with a similar phenotype as
usp-48. Experiments to determine their role in relation to
usp-48 are ongoing.